Strategic partnership There is a clear opportunity to leverage distribution partnerships with large medical device manufacturers and regional distributors, such as Nipro Corporation in Japan and existing North American distributors, to scale Orchid Safety Release Valve adoption across international markets.

Global expansion Focus sales efforts on expanding presence in Japan and other regions where partnered distributors are active; the recent Japan distribution agreement signals demand in international markets and potential for multi-region revenue growth.

Clinical impact Highlight the Orchid SRV’s potential to reduce IV catheter dislodgement and related waste, addressing cost containment and patient safety priorities that resonate with hospital procurement and value-based care initiatives.

Key hires Leverage the appointment of a chief medical officer board member to access clinical validation and leverage physician networks for trials, case studies, and credibility-driven selling to hospitals and GPOs.

Innovative credibility Capitalize on recognition from awards and patent activity to position Linear Health Sciences as a cutting-edge partner for institutions prioritizing innovation, potentially accelerating procurement conversations with healthcare systems and GPOs.